Islet Sciences Highlights Abstract at Arteriosclerosis, Thrombosis & Vascular Biology ATVB 2013

Published: May 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies for people with diabetes, announced today the acceptance and presentation of an abstract at the recent Arteriosclerosis, Thrombosis & Vascular Biology (ATVB) 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news